2,5-Dimethoxy-4-propylamphetamine

2,5-Dimethoxy-4-propylamphetamine
Clinical data
Other names	2,5-Dimethoxy-4-propylamphetamine
Legal status
Legal status	CA: Schedule I; DE: NpSG (Industrial and scientific use only); UK: Class A;
Identifiers
	IUPAC name 1-(2,5-Dimethoxy-4-propylphenyl)propan-2-amine;
CAS Number	63779-88-4 ; 53581-55-8 (hydrochloride);
PubChem CID	542051;
ChemSpider	472021 ;
UNII	L3P287BI9W;
ChEMBL	ChEMBL8569 ;
CompTox Dashboard (EPA)	DTXSID40337347 ;
Chemical and physical data
Formula	C14H23NO2
Molar mass	237.343 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O(c1cc(c(OC)cc1CC(N)C)CCC)C;
	InChI InChI=1S/C15H25NO2/c1-5-6-11-8-14(17-4)12(7-10(2)15)9-13(11)16-3/h8-10H,5-7,15H2,1-4H3 ; Key:UEEAUFJYLUJWQJ-UHFFFAOYSA-N ;
	(what is this?) (verify)

2,5-Dimethoxy-4-propylamphetamine (DOPR) is a psychedelic drug of the phenethylamine and amphetamine chemical classes. It was first synthesized by Alexander Shulgin, and was described in his book PiHKAL (Phenethylamines i Have Known And Loved). Shulgin described DOPR as a "heavy duty psychedelic", complete with alterations of the thought process and visual distortion. Very little data exists about the pharmacological properties, metabolism, and toxicity of DOPR.

The alternative structural isomer DOIP, with a 4-isopropyl substitution, is also known but is around ten times weaker than DOPR, with an active dose of some 20–30 mg (as compared to 2–5 mg for DOPR).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.